CYP 8.16% 22.5¢ cynata therapeutics limited

Ann: Ethics Approval to Commence Clinical Trial in COVID-19, page-274

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Some news items on the ongoing effects of this virus....

    ‘The range of lingering health effects for those that contract COVID-19 and survive remains to be seen.’

    https://www.marketwatch.com/story/another-warning-from-1918-spanish-flu-for-covid-19-survival-does-not-mean-that-individuals-fully-recovered-2020-08-18?mod=mw_more_headlines


    In a study published in the European Respiratory Journal on Wednesday, the researchers found extremely high levels of “angiotensin converting enzyme II,” or ACE-2, only in the area of the nose responsible for smelling. The ACE-2 enzyme is thought to be the gateway that allows coronavirus to enter the cells of the body and cause an infection.

    https://www.marketwatch.com/story/johns-hopkins-scientists-examining-weird-side-effects-of-covid-19-say-this-could-be-how-virus-gains-a-foothold-in-the-body-2020-08-19?mod=mw_more_headlines





 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.020(8.16%)
Mkt cap ! $40.68M
Open High Low Value Volume
24.5¢ 24.5¢ 22.5¢ $32.92K 143.1K

Buyers (Bids)

No. Vol. Price($)
1 21235 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 17528 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.